BRISTOL, England, Nov. 18 -- The University of Bristol issued the following news release:

* * *

Bristol researcher awarded over 850,000 pounds to develop new treatments for autoimmune diseases

A University of Bristol project aiming to develop next-generation therapeutics for autoimmune diseases has received over pound sterling850,000 in new funding through the beLAB1407 BRIDGE partnership, supported by Evotec and its global pharmaceutical collaborators.